CAMPERR: A multicenter, prospective, observational study to evaluate a cfDNA-based genome-wide methylation enrichment assay for multicancer early detection (MCED), identification of molecular residual disease, and relapse prognostication.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Gregory Idos, Faith L. Holmes, Lisa A. Boardman, Peter J. Mazzone, Nima Nabavizadeh, Phil Lammers, Manmeet Singh Ahluwalia, Arvinda Padmanabhan, Christopher Grant Burkeen, Charles H. Nash, Virginia L. Clyburn-Ipock, Ifeoma Roseline Okeke, Abigail B. Byrnes, Gerard A. Silvestri, Michelle H. Anderson, Kaytlin Landers, Jeremy B. Provance, Eduardo V. Sosa, Brian Allen, Brian I. Rini
Institutions: City Of Hope National Medical Center, Mayo Clinic, Cleveland Clinic, Oregon Health & Science University, Central Baptist Hospital, Northeast Georgia Medical Center, Baptist Health Floyd, Baptist Health Corbin, Medical University of South Carolina, Adela (United States), Vanderbilt University, Vanderbilt-Ingram Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Adela
OpenAlex ID: W7162690124
Cites:
Cited by:
Related to: